- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Granisetron market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Granisetron market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Chemotherapy accounting for % of the Granisetron global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Transdermal system segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Granisetron include Kyowa Kirin, Heron Therapeutics, Fresenius Kabi, Hikma Pharmaceuticals, and Teva, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Granisetron market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Transdermal system
Injection
Oral
Market segment by Application, can be divided into
Chemotherapy
Post operative
Market segment by players, this report covers
Kyowa Kirin
Heron Therapeutics
Fresenius Kabi
Hikma Pharmaceuticals
Teva
Cipla
Sandoz
Wockhardt
Mylan
APOTEX
Dr.Reddy's
Bluepharma
Natco Pharma
Akorn
Taro Pharmaceutical
Aurobindo
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Granisetron product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Granisetron, with revenue, gross margin and global market share of Granisetron from 2019 to 2022.
Chapter 3, the Granisetron competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Granisetron market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Granisetron research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Granisetron
1.2 Classification of Granisetron by Type
1.2.1 Overview: Global Granisetron Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Granisetron Revenue Market Share by Type in 2021
1.2.3 Transdermal system
1.2.4 Injection
1.2.5 Oral
1.3 Global Granisetron Market by Application
1.3.1 Overview: Global Granisetron Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Chemotherapy
1.3.3 Post operative
1.4 Global Granisetron Market Size & Forecast
1.5 Global Granisetron Market Size and Forecast by Region
1.5.1 Global Granisetron Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Granisetron Market Size by Region, (2017-2022)
1.5.3 North America Granisetron Market Size and Prospect (2017-2028)
1.5.4 Europe Granisetron Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Granisetron Market Size and Prospect (2017-2028)
1.5.6 South America Granisetron Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Granisetron Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Granisetron Market Drivers
1.6.2 Granisetron Market Restraints
1.6.3 Granisetron Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Kyowa Kirin
2.1.1 Kyowa Kirin Details
2.1.2 Kyowa Kirin Major Business
2.1.3 Kyowa Kirin Granisetron Product and Solutions
2.1.4 Kyowa Kirin Granisetron Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Kyowa Kirin Recent Developments and Future Plans
2.2 Heron Therapeutics
2.2.1 Heron Therapeutics Details
2.2.2 Heron Therapeutics Major Business
2.2.3 Heron Therapeutics Granisetron Product and Solutions
2.2.4 Heron Therapeutics Granisetron Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Heron Therapeutics Recent Developments and Future Plans
2.3 Fresenius Kabi
2.3.1 Fresenius Kabi Details
2.3.2 Fresenius Kabi Major Business
2.3.3 Fresenius Kabi Granisetron Product and Solutions
2.3.4 Fresenius Kabi Granisetron Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Fresenius Kabi Recent Developments and Future Plans
2.4 Hikma Pharmaceuticals
2.4.1 Hikma Pharmaceuticals Details
2.4.2 Hikma Pharmaceuticals Major Business
2.4.3 Hikma Pharmaceuticals Granisetron Product and Solutions
2.4.4 Hikma Pharmaceuticals Granisetron Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Hikma Pharmaceuticals Recent Developments and Future Plans
2.5 Teva
2.5.1 Teva Details
2.5.2 Teva Major Business
2.5.3 Teva Granisetron Product and Solutions
2.5.4 Teva Granisetron Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Teva Recent Developments and Future Plans
2.6 Cipla
2.6.1 Cipla Details
2.6.2 Cipla Major Business
2.6.3 Cipla Granisetron Product and Solutions
2.6.4 Cipla Granisetron Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Cipla Recent Developments and Future Plans
2.7 Sandoz
2.7.1 Sandoz Details
2.7.2 Sandoz Major Business
2.7.3 Sandoz Granisetron Product and Solutions
2.7.4 Sandoz Granisetron Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Sandoz Recent Developments and Future Plans
2.8 Wockhardt
2.8.1 Wockhardt Details
2.8.2 Wockhardt Major Business
2.8.3 Wockhardt Granisetron Product and Solutions
2.8.4 Wockhardt Granisetron Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Wockhardt Recent Developments and Future Plans
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business
2.9.3 Mylan Granisetron Product and Solutions
2.9.4 Mylan Granisetron Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Mylan Recent Developments and Future Plans
2.10 APOTEX
2.10.1 APOTEX Details
2.10.2 APOTEX Major Business
2.10.3 APOTEX Granisetron Product and Solutions
2.10.4 APOTEX Granisetron Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 APOTEX Recent Developments and Future Plans
2.11 Dr.Reddy's
2.11.1 Dr.Reddy's Details
2.11.2 Dr.Reddy's Major Business
2.11.3 Dr.Reddy's Granisetron Product and Solutions
2.11.4 Dr.Reddy's Granisetron Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Dr.Reddy's Recent Developments and Future Plans
2.12 Bluepharma
2.12.1 Bluepharma Details
2.12.2 Bluepharma Major Business
2.12.3 Bluepharma Granisetron Product and Solutions
2.12.4 Bluepharma Granisetron Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Bluepharma Recent Developments and Future Plans
2.13 Natco Pharma
2.13.1 Natco Pharma Details
2.13.2 Natco Pharma Major Business
2.13.3 Natco Pharma Granisetron Product and Solutions
2.13.4 Natco Pharma Granisetron Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Natco Pharma Recent Developments and Future Plans
2.14 Akorn
2.14.1 Akorn Details
2.14.2 Akorn Major Business
2.14.3 Akorn Granisetron Product and Solutions
2.14.4 Akorn Granisetron Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Akorn Recent Developments and Future Plans
2.15 Taro Pharmaceutical
2.15.1 Taro Pharmaceutical Details
2.15.2 Taro Pharmaceutical Major Business
2.15.3 Taro Pharmaceutical Granisetron Product and Solutions
2.15.4 Taro Pharmaceutical Granisetron Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Taro Pharmaceutical Recent Developments and Future Plans
2.16 Aurobindo
2.16.1 Aurobindo Details
2.16.2 Aurobindo Major Business
2.16.3 Aurobindo Granisetron Product and Solutions
2.16.4 Aurobindo Granisetron Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Aurobindo Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Granisetron Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Granisetron Players Market Share in 2021
3.2.2 Top 10 Granisetron Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Granisetron Players Head Office, Products and Services Provided
3.4 Granisetron Mergers & Acquisitions
3.5 Granisetron New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Granisetron Revenue and Market Share by Type (2017-2022)
4.2 Global Granisetron Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Granisetron Revenue Market Share by Application (2017-2022)
5.2 Global Granisetron Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Granisetron Revenue by Type (2017-2028)
6.2 North America Granisetron Revenue by Application (2017-2028)
6.3 North America Granisetron Market Size by Country
6.3.1 North America Granisetron Revenue by Country (2017-2028)
6.3.2 United States Granisetron Market Size and Forecast (2017-2028)
6.3.3 Canada Granisetron Market Size and Forecast (2017-2028)
6.3.4 Mexico Granisetron Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Granisetron Revenue by Type (2017-2028)
7.2 Europe Granisetron Revenue by Application (2017-2028)
7.3 Europe Granisetron Market Size by Country
7.3.1 Europe Granisetron Revenue by Country (2017-2028)
7.3.2 Germany Granisetron Market Size and Forecast (2017-2028)
7.3.3 France Granisetron Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Granisetron Market Size and Forecast (2017-2028)
7.3.5 Russia Granisetron Market Size and Forecast (2017-2028)
7.3.6 Italy Granisetron Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Granisetron Revenue by Type (2017-2028)
8.2 Asia-Pacific Granisetron Revenue by Application (2017-2028)
8.3 Asia-Pacific Granisetron Market Size by Region
8.3.1 Asia-Pacific Granisetron Revenue by Region (2017-2028)
8.3.2 China Granisetron Market Size and Forecast (2017-2028)
8.3.3 Japan Granisetron Market Size and Forecast (2017-2028)
8.3.4 South Korea Granisetron Market Size and Forecast (2017-2028)
8.3.5 India Granisetron Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Granisetron Market Size and Forecast (2017-2028)
8.3.7 Australia Granisetron Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Granisetron Revenue by Type (2017-2028)
9.2 South America Granisetron Revenue by Application (2017-2028)
9.3 South America Granisetron Market Size by Country
9.3.1 South America Granisetron Revenue by Country (2017-2028)
9.3.2 Brazil Granisetron Market Size and Forecast (2017-2028)
9.3.3 Argentina Granisetron Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Granisetron Revenue by Type (2017-2028)
10.2 Middle East & Africa Granisetron Revenue by Application (2017-2028)
10.3 Middle East & Africa Granisetron Market Size by Country
10.3.1 Middle East & Africa Granisetron Revenue by Country (2017-2028)
10.3.2 Turkey Granisetron Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Granisetron Market Size and Forecast (2017-2028)
10.3.4 UAE Granisetron Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Granisetron Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Granisetron Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Granisetron Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Granisetron Revenue (USD Million) by Region (2017-2022)
Table 5. Global Granisetron Revenue Market Share by Region (2023-2028)
Table 6. Kyowa Kirin Corporate Information, Head Office, and Major Competitors
Table 7. Kyowa Kirin Major Business
Table 8. Kyowa Kirin Granisetron Product and Solutions
Table 9. Kyowa Kirin Granisetron Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Heron Therapeutics Corporate Information, Head Office, and Major Competitors
Table 11. Heron Therapeutics Major Business
Table 12. Heron Therapeutics Granisetron Product and Solutions
Table 13. Heron Therapeutics Granisetron Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Fresenius Kabi Corporate Information, Head Office, and Major Competitors
Table 15. Fresenius Kabi Major Business
Table 16. Fresenius Kabi Granisetron Product and Solutions
Table 17. Fresenius Kabi Granisetron Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Hikma Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 19. Hikma Pharmaceuticals Major Business
Table 20. Hikma Pharmaceuticals Granisetron Product and Solutions
Table 21. Hikma Pharmaceuticals Granisetron Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Teva Corporate Information, Head Office, and Major Competitors
Table 23. Teva Major Business
Table 24. Teva Granisetron Product and Solutions
Table 25. Teva Granisetron Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Cipla Corporate Information, Head Office, and Major Competitors
Table 27. Cipla Major Business
Table 28. Cipla Granisetron Product and Solutions
Table 29. Cipla Granisetron Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Sandoz Corporate Information, Head Office, and Major Competitors
Table 31. Sandoz Major Business
Table 32. Sandoz Granisetron Product and Solutions
Table 33. Sandoz Granisetron Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Wockhardt Corporate Information, Head Office, and Major Competitors
Table 35. Wockhardt Major Business
Table 36. Wockhardt Granisetron Product and Solutions
Table 37. Wockhardt Granisetron Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Mylan Corporate Information, Head Office, and Major Competitors
Table 39. Mylan Major Business
Table 40. Mylan Granisetron Product and Solutions
Table 41. Mylan Granisetron Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. APOTEX Corporate Information, Head Office, and Major Competitors
Table 43. APOTEX Major Business
Table 44. APOTEX Granisetron Product and Solutions
Table 45. APOTEX Granisetron Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Dr.Reddy's Corporate Information, Head Office, and Major Competitors
Table 47. Dr.Reddy's Major Business
Table 48. Dr.Reddy's Granisetron Product and Solutions
Table 49. Dr.Reddy's Granisetron Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Bluepharma Corporate Information, Head Office, and Major Competitors
Table 51. Bluepharma Major Business
Table 52. Bluepharma Granisetron Product and Solutions
Table 53. Bluepharma Granisetron Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Natco Pharma Corporate Information, Head Office, and Major Competitors
Table 55. Natco Pharma Major Business
Table 56. Natco Pharma Granisetron Product and Solutions
Table 57. Natco Pharma Granisetron Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Akorn Corporate Information, Head Office, and Major Competitors
Table 59. Akorn Major Business
Table 60. Akorn Granisetron Product and Solutions
Table 61. Akorn Granisetron Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Taro Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 63. Taro Pharmaceutical Major Business
Table 64. Taro Pharmaceutical Granisetron Product and Solutions
Table 65. Taro Pharmaceutical Granisetron Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Aurobindo Corporate Information, Head Office, and Major Competitors
Table 67. Aurobindo Major Business
Table 68. Aurobindo Granisetron Product and Solutions
Table 69. Aurobindo Granisetron Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Global Granisetron Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 71. Global Granisetron Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 72. Breakdown of Granisetron by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Granisetron Players Head Office, Products and Services Provided
Table 74. Granisetron Mergers & Acquisitions in the Past Five Years
Table 75. Granisetron New Entrants and Expansion Plans
Table 76. Global Granisetron Revenue (USD Million) by Type (2017-2022)
Table 77. Global Granisetron Revenue Share by Type (2017-2022)
Table 78. Global Granisetron Revenue Forecast by Type (2023-2028)
Table 79. Global Granisetron Revenue by Application (2017-2022)
Table 80. Global Granisetron Revenue Forecast by Application (2023-2028)
Table 81. North America Granisetron Revenue by Type (2017-2022) & (USD Million)
Table 82. North America Granisetron Revenue by Type (2023-2028) & (USD Million)
Table 83. North America Granisetron Revenue by Application (2017-2022) & (USD Million)
Table 84. North America Granisetron Revenue by Application (2023-2028) & (USD Million)
Table 85. North America Granisetron Revenue by Country (2017-2022) & (USD Million)
Table 86. North America Granisetron Revenue by Country (2023-2028) & (USD Million)
Table 87. Europe Granisetron Revenue by Type (2017-2022) & (USD Million)
Table 88. Europe Granisetron Revenue by Type (2023-2028) & (USD Million)
Table 89. Europe Granisetron Revenue by Application (2017-2022) & (USD Million)
Table 90. Europe Granisetron Revenue by Application (2023-2028) & (USD Million)
Table 91. Europe Granisetron Revenue by Country (2017-2022) & (USD Million)
Table 92. Europe Granisetron Revenue by Country (2023-2028) & (USD Million)
Table 93. Asia-Pacific Granisetron Revenue by Type (2017-2022) & (USD Million)
Table 94. Asia-Pacific Granisetron Revenue by Type (2023-2028) & (USD Million)
Table 95. Asia-Pacific Granisetron Revenue by Application (2017-2022) & (USD Million)
Table 96. Asia-Pacific Granisetron Revenue by Application (2023-2028) & (USD Million)
Table 97. Asia-Pacific Granisetron Revenue by Region (2017-2022) & (USD Million)
Table 98. Asia-Pacific Granisetron Revenue by Region (2023-2028) & (USD Million)
Table 99. South America Granisetron Revenue by Type (2017-2022) & (USD Million)
Table 100. South America Granisetron Revenue by Type (2023-2028) & (USD Million)
Table 101. South America Granisetron Revenue by Application (2017-2022) & (USD Million)
Table 102. South America Granisetron Revenue by Application (2023-2028) & (USD Million)
Table 103. South America Granisetron Revenue by Country (2017-2022) & (USD Million)
Table 104. South America Granisetron Revenue by Country (2023-2028) & (USD Million)
Table 105. Middle East & Africa Granisetron Revenue by Type (2017-2022) & (USD Million)
Table 106. Middle East & Africa Granisetron Revenue by Type (2023-2028) & (USD Million)
Table 107. Middle East & Africa Granisetron Revenue by Application (2017-2022) & (USD Million)
Table 108. Middle East & Africa Granisetron Revenue by Application (2023-2028) & (USD Million)
Table 109. Middle East & Africa Granisetron Revenue by Country (2017-2022) & (USD Million)
Table 110. Middle East & Africa Granisetron Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Granisetron Picture
Figure 2. Global Granisetron Revenue Market Share by Type in 2021
Figure 3. Transdermal system
Figure 4. Injection
Figure 5. Oral
Figure 6. Granisetron Revenue Market Share by Application in 2021
Figure 7. Chemotherapy Picture
Figure 8. Post operative Picture
Figure 9. Global Granisetron Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Granisetron Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Granisetron Revenue Market Share by Region (2017-2028)
Figure 12. Global Granisetron Revenue Market Share by Region in 2021
Figure 13. North America Granisetron Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Granisetron Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Granisetron Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Granisetron Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Granisetron Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Granisetron Market Drivers
Figure 19. Granisetron Market Restraints
Figure 20. Granisetron Market Trends
Figure 21. Kyowa Kirin Recent Developments and Future Plans
Figure 22. Heron Therapeutics Recent Developments and Future Plans
Figure 23. Fresenius Kabi Recent Developments and Future Plans
Figure 24. Hikma Pharmaceuticals Recent Developments and Future Plans
Figure 25. Teva Recent Developments and Future Plans
Figure 26. Cipla Recent Developments and Future Plans
Figure 27. Sandoz Recent Developments and Future Plans
Figure 28. Wockhardt Recent Developments and Future Plans
Figure 29. Mylan Recent Developments and Future Plans
Figure 30. APOTEX Recent Developments and Future Plans
Figure 31. Dr.Reddy's Recent Developments and Future Plans
Figure 32. Bluepharma Recent Developments and Future Plans
Figure 33. Natco Pharma Recent Developments and Future Plans
Figure 34. Akorn Recent Developments and Future Plans
Figure 35. Taro Pharmaceutical Recent Developments and Future Plans
Figure 36. Aurobindo Recent Developments and Future Plans
Figure 37. Global Granisetron Revenue Share by Players in 2021
Figure 38. Granisetron Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 39. Global Top 3 Players Granisetron Revenue Market Share in 2021
Figure 40. Global Top 10 Players Granisetron Revenue Market Share in 2021
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 42. Global Granisetron Revenue Share by Type in 2021
Figure 43. Global Granisetron Market Share Forecast by Type (2023-2028)
Figure 44. Global Granisetron Revenue Share by Application in 2021
Figure 45. Global Granisetron Market Share Forecast by Application (2023-2028)
Figure 46. North America Granisetron Sales Market Share by Type (2017-2028)
Figure 47. North America Granisetron Sales Market Share by Application (2017-2028)
Figure 48. North America Granisetron Revenue Market Share by Country (2017-2028)
Figure 49. United States Granisetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada Granisetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico Granisetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe Granisetron Sales Market Share by Type (2017-2028)
Figure 53. Europe Granisetron Sales Market Share by Application (2017-2028)
Figure 54. Europe Granisetron Revenue Market Share by Country (2017-2028)
Figure 55. Germany Granisetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Granisetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Granisetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Granisetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Granisetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Granisetron Sales Market Share by Type (2017-2028)
Figure 61. Asia-Pacific Granisetron Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Granisetron Revenue Market Share by Region (2017-2028)
Figure 63. China Granisetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Granisetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South Korea Granisetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Granisetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Granisetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Granisetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Granisetron Sales Market Share by Type (2017-2028)
Figure 70. South America Granisetron Sales Market Share by Application (2017-2028)
Figure 71. South America Granisetron Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Granisetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Granisetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East and Africa Granisetron Sales Market Share by Type (2017-2028)
Figure 75. Middle East and Africa Granisetron Sales Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Granisetron Revenue Market Share by Country (2017-2028)
Figure 77. Turkey Granisetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Granisetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. UAE Granisetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
